Coloplast AS Overview
Latest P/E ratio for Coloplast AS: 37.74 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow37.74
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Coloplast AS (CLPBY) currently reports a P/E ratio of 37.74. That is above the Healthcare sector average of 25.9. Use the charts on this page to explore Coloplast AS's P/E ratio history and peer comparisons.
Coloplast AS's P/E ratio of 37.74 is higher than the Healthcare sector average of 25.9. That is roughly 45.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Coloplast AS's market price to a fundamental measure such as earnings, sales, or book value. At 37.74, CLPBY can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 37.74, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.9. From there, open related valuation or income-statement pages for Coloplast AS, and consider following CLPBY for alerts when major investors trade the stock.
Coloplast AS is classified in the Healthcare sector. On P/E ratio, it currently shows 37.74 versus a sector average near 25.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLPBY with unrelated industries.
